Huntington's disease treatment shows success in slowing progression for first time, UK trial finds
By
_zie
Pure flour-power. Hearty enough to carry you through lunch.
Summary
For the first time, doctors have successfully treated Huntington's disease, a devastating inherited neurodegenerative condition that kills brain cells and combines features of dementia, Parkinson's, and motor neurone disease. The UK trial, led by Professors Ed Wild and Sarah Tabrizi, has produced an emotional breakthrough with a treatment that can slow the disease's progression and transform patients' lives.
Key quotes
· 3 pulledOne of the cruellest and most devastating diseases – Huntington's – has been successfully treated for the first time, say doctors.
An emotional research team became tearful as they described...
One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful doctors tell BBC.
You might also wanna read
Experimental daraxonrasib pill nearly doubles survival time in advanced pancreatic cancer trial
A new experimental pill called daraxonrasib has shown promising results in extending survival for patients with advanced pancreatic cancer.
cnbc.com·11h ago
Daily pill daraxonrasib doubles survival in advanced pancreatic cancer, clinical trial shows
A clinical trial has shown that a daily pill called daraxonrasib can double survival time for patients with advanced pancreatic cancer, one
theguardian.com·12h ago
Experimental pill daraxonrasib nearly doubles survival time in advanced pancreatic cancer patients
A novel experimental pill called daraxonrasib has shown promise in extending survival for patients with advanced pancreatic cancer. The drug
chicagotribune.com·12h ago
Multi-omics and single-cell CRISPRi screening maps Alzheimer's GWAS variants to TSPAN14 effector gene in microglia
This study presents a variant-to-gene (V2G) mapping effort for Alzheimer disease (AD) that integrates ten brain-relevant genomics datasets—i
Gourmand Syndrome: A Rare Eating Disorder Following Frontal Lobe Injury
Gourmand syndrome is a rare, benign eating disorder that typically develops 6-12 months after a frontal lobe injury, particularly in the rig
en.wikipedia.org·4mo ago
First In-Vivo Gene-Editing Therapy Successfully Saves Newborn's Life in 2025
In 2025, doctors and scientists in the U.S. successfully performed the world's first custom gene-editing therapy inside a living person—a ne
popularmechanics.com·5mo ago